PBYI Q1 2018 Earnings — Puma Biotechnology, Inc. Revenue & Financial Results | Market Cap Arena

PBYIPuma Biotechnology, Inc.

$299M

Q1 2018 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$67M

Gross Profit

$60M90.4% margin

Operating Income

-$23M-35.2% margin

Net Income

-$24M-36.6% margin

EPS (Diluted)

$-0.65

QoQ Revenue Growth

+207.9%

Cash Flow

Operating Cash Flow

-$6M

Free Cash Flow

-$6M

Stock-Based Comp.

$25M

Balance Sheet

Total Assets

$170M

Total Liabilities

$112M

Stockholders' Equity

$57M

Cash & Equivalents

$79M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$67M	$0	—
Gross Profit	$60M	$0	—
Operating Income	-$23M	-$73M	+68.0%
Net Income	-$24M	-$73M	+66.6%